U.S. vaccine market to hit $17B by 2018; Military research probes HIV weaknesses to find vaccine;

> Scientists from the U.S. Military HIV Research Program in Maryland think they are finding weaknesses in HIV that can lead to an effective vaccine. Story

> A study by Transparency Market Research shows the U.S. vaccines market will reach $17.4 billion by 2018. More

> Austrian biotech Intercell launched its JEEV vaccine to combat Japanese encephalitis in India. News

> In New Zealand, doctors are recording a spike in demand for the meningococcal C vaccine, after a 12-year-old girl succumbed to it and died. Story

> Interim results from a Phase II trial conducted in India to test a tuberculosis vaccine are expected to be released "soon," according to The Hindu. Article